Bionomics, Merck in $172M Pain Pact

Bionomics Limited today announced an agreement with Merck, known as MSD outside the United States and Canada, to discover and develop novel small molecule candidates for the treatment of chronic pain, including neuropathic pain.

http://www.drugs.com/clinical_trials/bionomics-merck-172m-pain-pact-15906.html?